Work

Supplementary Figure 3 from Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping

Year: 2023

Type: supplementary-materials

Abstract: Representative photomicrographs from 3 patient samples demonstrating tumor localization on the left (H&E staining) and MET protein expression by IHC on the right. High membranous MET protein expression by IHC is present in all samples (H-score = 300).

DOI: 10.1158/2159-8290.22531580

Authors: Paul K. Paik, Alexander Drilon, Pang-Dian Fan, Helena Yu, Natasha Rekhtman, Michelle S. Ginsberg, Laetitia Borsu, Nikolaus Schultz, Michael F. Berger, Charles M. Rudin, Marc Ladanyi

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362542382

Cites:

Cited by:

Related to: 10